Citation Impact
Citing Papers
Cyclin E1 Deregulation Occurs Early in Secretory Cell Transformation to Promote Formation of Fallopian Tube–Derived High-Grade Serous Ovarian Cancers
2013
Helicobacter pylori and Esophageal Cancer Risk: A Meta-analysis
2008
ES cells derived from cloned and fertilized blastocysts are transcriptionally and functionally indistinguishable
2006
Molecular mechanisms mediating metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Role of Positron Emission Tomography for the Monitoring of Response to Therapy in Breast Cancer
2015
Breast cancer
2019 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
2021
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
2010 Standout
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Incorporating Tumor Characteristics to the American Joint Committee on Cancer Breast Cancer Staging System
2017
Cancer statistics, 2020
2020 Standout
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
A simple method for assessing sample sizes in microarray experiments
2006
Bile acid–microbiota crosstalk in gastrointestinal inflammation and carcinogenesis
2017 Standout
Proteasome inhibitors in cancer therapy
2017
The evidence framework for precision cancer medicine
2017
Tissue-specific actions of FXR in metabolism and cancer
2014
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis
2010
Regulation and Functions of the ER-Associated Nrf1 Transcription Factor
2022 StandoutNobel
Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial
2018
Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice
2020 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies
2019 Standout
An assessment of recently published gene expression data analyses: reporting experimental design and statistical factors
2006
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Comparative effectiveness of imaging modalities to determine metastatic breast cancer treatment response
2014
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Targeted therapies in bladder cancer: an overview of in vivo research
2015
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Colorectal cancer
2019 Standout
A Postoperative Nomogram for Local Recurrence Risk in Extremity Soft Tissue Sarcomas After Limb-Sparing Surgery Without Adjuvant Radiation
2011
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Thyroid hormone contributes to the hypolipidemic effect of polyunsaturated fatty acids from fish oil: in vivo evidence for cross talking mechanisms
2011
Growth-induced stress enhances epithelial-mesenchymal transition induced by IL-6 in clear cell renal cell carcinoma via the Akt/GSK-3β/β-catenin signaling pathway
2017
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Oesophageal carcinoma
2013 Standout
Bladder cancer
2016 Standout
Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding
2019
Deep learning in histopathology: the path to the clinic
2021 Standout
Liquid biopsies come of age: towards implementation of circulating tumour DNA
2017 Standout
Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner
2010
Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions
2017
How were new medicines discovered?
2011 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Current understanding of the human microbiome
2018 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Active autophagy in the tumor microenvironment: A novel mechanism for cancer metastasis
2012
Helicobacter pyloriinfection and esophageal cancer risk: An updated meta-analysis
2013
Tiny microbes, enormous impacts: what matters in gut microbiome studies?
2016
Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research
2010 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Future directions of bone-targeted therapy for metastatic breast cancer
2010
Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
2013 Standout
Rising Proportion of Young Individuals With Rectal and Colon Cancer
2018
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
2015
The Impact of Dietary Fiber on Gut Microbiota in Host Health and Disease
2018 Standout
Salvage surgery for locoregional recurrence or persistent tumor after high dose chemoradiotherapy for locally advanced non-small cell lung cancer
2016
Molecular mechanisms and clinical applications of angiogenesis
2011 StandoutNature
MetaboAnalyst 3.0—making metabolomics more meaningful
2015 Standout
The NCI60 human tumour cell line anticancer drug screen
2006 Standout
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
2007 StandoutNature
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
The history and future of targeting cyclin-dependent kinases in cancer therapy
2015 Standout
Emerging targeted agents in metastatic breast cancer
2013
The human microbiome: at the interface of health and disease
2012 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Nrf2- and ATF4-Dependent Upregulation of xCT Modulates the Sensitivity of T24 Bladder Carcinoma Cells to Proteasome Inhibition
2014
Relationships between surface, volume, and thickness of iliac trabecular bone in aging and in osteoporosis. Implications for the microanatomic and cellular mechanisms of bone loss.
1983 Standout
Menopausal changes in bone remodeling.
1978
A review of human carcinogens—Part B: biological agents
2009 Standout
Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay
2016
Bladder Cancer
2020 Standout
CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies?
2011
Breast Cancer Treatment
2019 Standout
Unmet Clinical Need: Developing Prognostic Biomarkers and Precision Medicine to Forecast Early Tumor Relapse, Detect Chemo-Resistance and Improve Overall Survival in High-Risk Breast Cancer
2020
Resistance to proteasome inhibitors and other targeted therapies in myeloma
2018
Erythrodermic mycosis fungoides and Sézary syndrome treated with extracorporeal photopheresis as part of a multimodality regimen: A single‐centre experience
2015
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
2013
Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation–associated thrombotic microangiopathy
2011
Thyroid Hormone Regulation of Metabolism
2014 Standout
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
2010
CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
2014
NCCN Task Force Report: Bone Health in Cancer Care
2013
Global cancer statistics, 2012
2015 Standout
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
mTORC1 and ferroptosis: Regulatory mechanisms and therapeutic potential
2021
A review of feature selection techniques in bioinformatics
2007 Standout
Works of Caimiao Wei being referenced
Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitization with Capecitabine
2012
PEA-15 Induces Autophagy in Human Ovarian Cancer Cells and Is Associated with Prolonged Overall Survival
2008
Distinctive Expression Pattern of ErbB Family Receptors Signifies an Aggressive Variant of Bladder Cancer
2007
Sample size for detecting differentially expressed genes in microarray experiments
2004
Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype
2017
Transplant-Associated Microangiopathy in Patients Receiving Tacrolimus Following Allogeneic Stem Cell Transplantation: Risk Factors and Response to Treatment
2007
LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients
2012
Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia
2007
The dominant negative thyroid hormone receptor β-mutant Δ337T alters PPARα signaling in heart
2006
Definitive Reirradiation for Locoregionally Recurrent Non-Small Cell Lung Cancer With Proton Beam Therapy or Intensity Modulated Radiation Therapy: Predictors of High-Grade Toxicity and Survival Outcomes
2014
A CXCR4 Antagonist CTCE-9908 Inhibits Primary Tumor Growth and Metastasis of Breast Cancer
2008
Indole-3-carbinol and its N-alkoxy derivatives preferentially target ERα-positive breast cancer cells
2014
Impact of a Biomarker-Based Strategy on Oncology Drug Development: A Meta-analysis of Clinical Trials Leading to FDA Approval
2015
Meta-analyses of colorectal cancer risk factors
2013
Long-term Results of Prospective Trial of Surgery Alone With Selective Use of Radiation for Patients With T1 Extremity and Trunk Soft Tissue Sarcomas
2007
Female Gender Is Associated With a Worse Survival After Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Competing Risk Analysis
2014
A Prospective Study of Bone Tumor Response Assessment in Metastatic Breast Cancer
2012
Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma
2012
A role for BMP-induced homeobox geneMIXL1in acute myelogenous leukemia and identification of type I BMP receptor as a potential target for therapy
2014
FXR silencing in human colon cancer by DNA methylation and KRAS signaling
2013
The effect of extracorporeal photopheresis alone or in combination therapy on circulatingCD 4+Foxp3+CD 25−T cells in patients with leukemic cutaneous T‐cell lymphoma
2015
TBCRC-010: Phase I/II Study of Dasatinib in Combination with Zoledronic Acid for the Treatment of Breast Cancer Bone Metastasis
2016
Epithelial to mesenchymal transition is associated with rapamycin resistance
2015